Burgess R W, Crowhurst J A
Queen Victoria Hospital, Rose Park, South Australia.
Anaesth Intensive Care. 1989 Nov;17(4):492-5. doi: 10.1177/0310057X8901700417.
During 1987 a confidential survey of all hospitals in Australia providing obstetric services was undertaken to determine the antacid medications used routinely as prophylaxis against acid aspiration pneumonitis. Of the 567 hospitals surveyed, 379 (67%) responded. Of these, 243 hospitals provide an obstetric service which includes caesarean section, and 67% of these perform less than 500 deliveries per annum. Aspiration prophylaxis during labour was used in 22.4% of responding hospitals. Prior to elective caesarean section, 11.5% used no prophylaxis, and 39.4% used particulate antacids such as magnesium trisilicate mixture (33.3%) or Mylanta (6.1%). Sodium citrate mixture was the most popular therapy (37%). Results were similar in the emergency caesarean section group. The use of cimetidine or ranitidine was uncommon in all groups. Results of this survey suggest marked differences in attitudes towards acid aspiration prophylaxis between Australian and British obstetric anaesthetic practices.
1987年，对澳大利亚所有提供产科服务的医院进行了一项保密调查，以确定常规用作预防酸性吸入性肺炎的抗酸药物。在接受调查的567家医院中，379家（67%）作出了回应。其中，243家医院提供包括剖腹产在内的产科服务，其中67%的医院每年分娩量不到500例。22.4%的回应医院在分娩期间使用了预防吸入措施。在择期剖腹产前，11.5%的医院未采取预防措施，39.4%的医院使用了颗粒状抗酸剂，如三硅酸镁混合物（33.3%）或氢氧化铝镁混悬液（6.1%）。枸橼酸钠混合物是最常用的治疗方法（37%）。急诊剖腹产组的结果相似。在所有组中，使用西咪替丁或雷尼替丁的情况并不常见。这项调查结果表明，澳大利亚和英国产科麻醉实践在预防酸性吸入方面的态度存在显著差异。
